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Abstract
Background: The angiotensin-converting enzyme (ACE) gene in humans has an insertion-deletion
(I/D) polymorphic state in intron 16 on chromosome 17q23. This polymorphism has been widely
investigated in different populations due to its association with the renin-angiotensin system.
However, similar studies for Arab populations are limited. This study addresses the distribution of
the ACE gene polymorphism in three Arab populations (Egyptians, Jordanians and Syrians).
Findings: The polymorphisms of ACE gene were investigated using polymerase chain reaction for
detection of an I/D mutation. The results showed a high frequency of the ACE D allele among the
three Arab populations, Egyptians (0.67), Jordanians (0.66) and Syrians (0.60), which is similar to
those obtained from previous studies for Arab populations.
Conclusion: The relationship between ACE alleles and disease in these three Arab populations is
still not known, but the present results clearly suggest that geographic origin should be carefully
considered in the increasing number of studies on the association between ACE alleles and disease
etiology. This study adds to the data showing the wide variation in the distribution of the ACE
alleles in different populations and highlights that great care needs to be taken when interpreting
clinical data on the association of the ACE alleles with different diseases.
Background
Angiotensin-converting enzyme (ACE), a key enzyme of
the rennin-angiotensin system, is localized in the kidney
[1]. The ACE catalyzes the conversion of angiotensin I to
the biologically active peptide, angiotensin II, which is
involved in the control of fluid-electrolyte balance and
systemic blood pressure [2]. The ACE gene is mapped to
chromosome 17q23 and it has been widely investigated.
The insertion/deletion (I/D) polymorphism of ACE was
discovered by Rigat et al. [3] and it is characterized by the
presence (insertion) or absence (deletion) of a 287 bp
AluYa5 element inside intron 16 producing three geno-
types (II homozygote, ID heterozygote and DD homozy-
gote) [3]. Although the I/D polymorphism is located in a
non-coding region (i.e. intron) of the ACE gene, several
investigators have found that the D allele is related to
increased activity of ACE in serum [3,4]. The highest
serum ACE activity was seen in the DD genotype while the
lowest was seen in the II genotype [3]. Several investiga-
tions suggested the genetic predisposition of the ACE I/D
polymorphism with several diseases including coronary
heart diseases [5], stroke [6], hypertension [7] and diabe-
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tes mellitus [8]. However, conflicting results have been
reported regarding the association between ACE polymor-
phism and disease [9,10]. Moreover, various reports were
published suggesting inter-ethnic variations in the fre-
quency of allelic forms of the ACE genes [11,12].
In this study we aim to investigate the distribution of ACE
gene I/D polymorphism in three Arab populations (Egyp-
tians, Jordanians and Syrians). The three Arab popula-
tions have a mixed genetic background with an ethnic
heterogeneity. Most of the three populations are of Medi-
terranean or Arabic origin that migrated from the Arabian
Peninsula and surrounding areas.
Methods
The human population samples used for this study have
been described previously and were available from previ-
ous studies [13]. The samples studied were collected from
unrelated individuals from three Arab populations:
(Egyptians, Jordanians and Syrians) under institutionally
approved internal review board protocols with informed
consent. DNA was prepared from blood leukocytes by
standard methods. A total of 164 Egyptians from Ismailia,
and Sinai, 60 Jordanians and 70 Syrians were analyzed.
The Egyptian samples were from Ismailia (112 subjects),
and the Sinai (52 subjects). The specific segment of ACE
gene was amplified by polymerase chain reaction (PCR)
using the following primers [14]: ACE-F (5-CTGGAGAC-
CACTCCCATCCTTTCT-3) and ACE-R (5-GATGT-
GGCCATCACATTCGTCAGAT-3). PCR amplification was
carried out in 25 μl reactions containing 20–100 ng of
template DNA, 40 pM of each oligonucleotide primers,
200 μM dNTPs, 50 mM KCl, 1.5 mM MgCl2, 10 mM Tris-
HCl (pH 8.4) and Taq DNA polymerase (1.25 Units). The
reaction were subjected to 32 cycles: an initial denatura-
tion of 60 s at 94°C, 30 s denaturation at 94°C, 45 s at the
annealing temperature 58°C, extension at 72°C for 45 s.
Following the amplification cycles, a final extension was
performed at 72°C for 10 min. For analysis, 20 μl of each
sample was fractionated on a 2% agarose gel with 0.05 μg/
ml ethidium bromide. PCR products were directly visual-
ized using UV fluorescence. The homozygous individuals
for the D allele (DD genotype) were identified by the pres-
ence of a single 190 bp PCR product. The homozygous for
the I allele (II genotype) were identified by the presence of
a single 490 bp PCR product. The heterozygous individu-
als (ID genotype) were identified by the presence of both
190 and 490 bp PCR products. Because the D allele in het-
erozygous samples is preferentially amplified, all samples
that were typed initially as a DD genotype were reanalyzed
using an insertion-specific primer pair, as reported by
Lindpaintner et al. [15], except that the annealing temper-
ature was 67°C. A 335 bp band was obtained only in the
presence of the I allele and no bands were detected for
samples with DD genotype.
Statistical analysis was performed using SPSS version 15
statistical package for windows. Allele and genotype fre-
quencies were calculated by direct counting; the Hardy-
Weinberg equilibrium was assessed by an exact test pro-
vided by the Arlequin program [16].
Results and discussion
As shown in Table 1, 16 individuals from Egypt living in
Ismailia were homozygous for the II genotype, 40 were
heterozygous for the ID  genotype and 56 were
homozygous for the DD genotype, giving a D allelic fre-
quency of 0.679. Among 52 Egyptians living in Sinai that
Table 1: Allele frequencies and heterozygosities of the ACE gene among Egyptians, Jordanians and Syrians.
ACE Allele Frequency Heterozygosity
Population N ACE Genotype Number Observed
(and Expected)
ID Observed Expected
Egypt-Ismailia 112 II 16 (13.66) 0.321 0.679 0.357 0.474
ID 40 (45.76)
DD 56 (52.59)
Egypt-Sinai 52 II 4 (6.34) 0.337 0.663 0.519 0.474
ID 27 (21.24)
DD 21 (24.42)
Egypt-Total 164 II 20 (17.43) 0.326 0.674 0.409 0.473
ID 67 (72.07)
DD 77 (74.50)
Syrians 70 II 9 (11.20) 0.400 0.600 0.543 0.527
ID 38 (33.60)
DD 23 (25.20)
Jordanians 60 II 13 (7.01) 0.342 0.658 0.250 0.505
ID 15 (25.9)
DD 32 (27)BMC Research Notes 2009, 2:99 http://www.biomedcentral.com/1756-0500/2/99
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were studied, 4 individuals were homozygous for the II
genotype, 27 were heterozygous for the ID genotype and
21 were homozygous for the DD genotype, giving a D
allelic frequency of 0.663. There was no significant statis-
tical difference between the two Egyptian groups (X2 =
4.25, P-value = 0.119). The average frequency of the D
allele among the two studied Egyptian groups was 0.674.
As regards the studied individuals from Syria, we found
that 9 individuals were homozygous for the II genotype,
38 were heterozygous for the ID genotype and 23 were
homozygous for the DD genotype, giving a D allelic fre-
quency of 0.600. As regards the Jordanians, we found that
13 individuals were homozygous for the II genotype, 15
were heterozygous for the ID  genotype and 32 were
homozygous for the DD genotype, giving a D allelic fre-
quency of 0.658. Based on the allele frequencies, it is pos-
sible to predict the genotype frequency considering that
they follow the Hardy-Weinberg equilibrium. This means
that the frequencies have a binomial distribution accord-
ing to the following equation: p2+2pq + q2 = 1, where p
and q are the allelic frequencies of I and D, respectively,
and p2, 2pq and q2 are the genotype frequencies of II, ID,
and DD, respectively. No significant deviations from the
Hardy-Weinberg equilibrium were observed except for
Jordanians which probably represent a random statistical
fluctuation. Table 2 shows the frequency of the D allele in
the populations analyzed here as well as selected popula-
tions from previous studies.
The present study investigated for the first time, the fre-
quency of the ACE gene I/D polymorphism in randomly
selected Syrian and Jordanian individuals. The frequency
of the D allele of the ACE gene (Table 2) among Syrians
(0.60), Jordanians (0.66) and Egyptians from Ismailia
(0.68), and from Sinai (0.66) is similar to that in other
Arabs, such as the Tunisians (0.76) [17], the Algerians
(0.73) [17], the Somalis (0.73) [18], the Omanis (0.71)
[18], the Moroccans (0.70) [17], the Emiratis (0.61–0.66)
[18,19], and the Sudanese (0.64) [18]. Our result for the
Egyptian samples was slightly different from previously
reported D allele frequency for an Egyptian population
sample from Cairo [20]. This difference most likely is due
to the composition of the samples used in the two studies.
Overall similarity in the I/D allele's frequencies of the
Egyptian, Jordanian and Syrian population samples stud-
ied with other Arab populations suggests that there may
have been some admixture among them.
Compared to other geographic groups (Table 2) the fre-
quency of the D allele in the Arab populations is among
the highest reported. The frequency of the D allele is high-
est among sub-Saharan Africans [11] and Arabs (0.60–
0.76) [17-20], moderate for Caucasians (0.46–0.51)
Table 2: The frequency of I/D polymorphism of the ACE gene in the current study compared to different ethnic groups in different 
studies.
Allele Frequency
Ethnic Group ID Number of Individuals
Tunisians [17] 0.24 0.76 47
Algerians [17] 0.27 0.73 48
Somalis [18] 0.27 0.73 53
Omanis [18] 0.29 0.71 127
Egyptians [20] 0.28 0.72 188
Moroccans [17] 0.30 0.70 300
Egyptians [present study] 0.33 0.67 164
Jordanians [present study] 0.34 0.66 60
Emiratis [19] 0.34 0.66 159
Sudanese [18] 0.36 0.64 121
Emiratis [18] 0.39 0.61 111
Syrians [present study] 0.40 0.60 70
Nigerians [11] 0.41 0.59 80
Caucasians [11] 0.49 0.51 186
Caucasians [21] 0.54 0.46 733
Indians [12] 0.54 0.46 166
Japanese [22] 0.65 0.35 136
Japanese [23] 0.67 0.33 113
Chinese [24] 0.71 0.29 189
Yanomami Indians [11] 0.85 0.15 49
Samoans [11] 0.91 0.09 58
Australian Aborigines [25] 0.97 0.03 184
Data from previous studies is denoted by the citations.BMC Research Notes 2009, 2:99 http://www.biomedcentral.com/1756-0500/2/99
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[11,21], and low among various Asian populations (0.29–
0.46) [12,22-24]. The Yanomami Indians, Samoans and
Australian Aborigines seem to have the lowest frequen-
cies: 0.15, 0.09 and 0.03, respectively [11,25].
The worldwide distribution of the D allele (Table 2) sug-
gests that the ancestral state present in the human popula-
tion was the D allele and that an AluYa5 (the youngest
AluY subfamily in the human genome) element later
inserted at the locus, generating the I allele and creating an
ancestral polymorphism in the pre-migration African
human population. As human populations moved out of
Africa during Paleolithic migrations 100,000 years ago
[26], they carried with them portions of this ancestral I/D
polymorphism. As each different human population
migrated to its new location and established itself, they
were subject to different evolutionary forces (e.g., genetic
drift, selective pressure, founder effects, and gene flow),
which shaped the allele frequencies we observe in these
populations today.
Although the I/D polymorphism in the ACE gene implies
either an insertion or a deletion, there is only an insertion
event, and the D allele represents the ancestral state of the
ACE gene without an Alu repeat insertion in the region of
intron 16 [14]. In fact, nearly half of the human genome
is derived from transposable elements, and among them,
the primate-specific Alu  elements are most abundant,
accounting for more than 10% of the human genome.
In conclusion, the results of the distribution of the ACE I/
D gene polymorphism obtained for the D allele among
Egyptians, Jordanians and Syrians are comparable to
those obtained from previous studies in other Arabs, add
to the data indicating the wide variations observed in the
frequency of the ACE alleles among the peoples of the
world and highlights that great care needs to be taken
when interpreting clinical data on the association of the
ACE alleles with different diseases.
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